Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
389 GBX | +0.65% | +0.52% | +10.98% |
05-07 | AstraZeneca target raised; Antofagasta lowered | AN |
03-25 | Chemring Director Ord sells GBP500,000 in shares | AN |
Sales 2024 * | 508M 645M 876M | Sales 2025 * | 548M 695M 945M | Capitalization | 1.06B 1.34B 1.83B |
---|---|---|---|---|---|
Net income 2024 * | 54M 68.55M 93.17M | Net income 2025 * | 59M 74.89M 102M | EV / Sales 2024 * | 2.21 x |
Net Debt 2024 * | 64.44M 81.8M 111M | Net Debt 2025 * | 68.83M 87.37M 119M | EV / Sales 2025 * | 2.06 x |
P/E ratio 2024 * |
20.3
x | P/E ratio 2025 * |
18.3
x | Employees | 2,600 |
Yield 2024 * |
2.03% | Yield 2025 * |
2.26% | Free-Float | 98.32% |
Latest transcript on Chemring Group PLC
1 day | +0.65% | ||
1 week | +0.52% | ||
Current month | +3.73% | ||
1 month | +8.36% | ||
3 months | +10.20% | ||
6 months | +29.67% | ||
Current year | +10.98% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Ord
CEO | Chief Executive Officer | 57 | 18-05-31 |
Director of Finance/CFO | 45 | 10-31 | |
Andrew Davies
BRD | Director/Board Member | 57 | 16-05-16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sarah Ellard
BRD | Director/Board Member | 54 | 93-12-31 |
Laurie Bowen
BRD | Director/Board Member | 62 | 19-07-31 |
Chairman | 70 | 16-04-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 10 M€ | -3.35% | - | |
0.00% | 45 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-15 | 389 | +0.65% | 638,535 |
24-05-14 | 386.5 | +2.11% | 1,003,946 |
24-05-13 | 378.5 | -1.82% | 778,749 |
24-05-10 | 385.5 | -0.26% | 582,021 |
24-05-09 | 386.5 | -0.13% | 561,366 |
Delayed Quote London S.E., May 15, 2024 at 11:35 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.98% | 1.32B | |
+25.21% | 140B | |
+0.32% | 70.16B | |
+22.74% | 51.23B | |
+42.31% | 44.16B | |
+5.45% | 41.94B | |
+49.16% | 32.63B | |
+79.58% | 24.5B | |
+13.79% | 22.37B | |
+26.51% | 20.21B |
- Stock Market
- Equities
- CHG Stock